DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Porpaczy E, Tripolt S, Hoelbl-Kovacic A. et al.
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Blood 2018;
132: 694-706
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.